Entrectinib Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of entrectinib that may be used in the treatment of breast, central nervous system (CNS), colon, cervical, esophageal and esophagogastric junction, follicular, gastric, hepatobiliary, endometrial, ovarian/fallopian tube/primary peritoneal, occult primary, vaginal, vulvar, and rectal cancers, hurthle cell carcinoma, cutaneous melanoma, non-small cell lung cancer (NSCLC), ampullary, appendiceal, small bowel and pancreatic adenocarcinomas, anaplastic and papillary carcinomas, soft tissue sarcoma, uterine sarcoma, extrapulmonary poorly differentiated neuroendocrine carcinoma/large or small cell carcinoma/mixed neuroendocrine-non-neuroendocrine neoplasm, and salivary gland and gastrointestinal stromal tumors (GIST).

**Synonyms:** - Entrectinib monotherapy - Rozlytrek Regimen